Literature DB >> 11402015

Dr operon-associated invasiveness of Escherichia coli from pregnant patients with pyelonephritis.

P Goluszko1, D Niesel, B Nowicki, R Selvarangan, S Nowicki, A Hart, E Pawelczyk, M Das, P Urvil, R Hasan.   

Abstract

We used a gentamicin protection assay to assess the ability of gestational pyelonephritis isolates of Escherichia coli to invade HeLa cells. The ability to enter HeLa cells was strongly associated with the presence of Dr operons coding for Dr adhesins. In contrast, the nonivasive isolates predominantly expressed papG, coding for P fimbriae.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11402015      PMCID： PMC98548          DOI： 10.1128/IAI.69.7.4678-4680.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  15 in total

1.  Molecular cloning and characterization of Dr-II, a nonfimbrial adhesin-I-like adhesin isolated from gestational pyelonephritis-associated Escherichia coli that binds to decay-accelerating factor.

Authors:  T Q Pham; P Goluszko; V Popov; S Nowicki; B J Nowicki
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Dr fimbriae operon of uropathogenic Escherichia coli mediate microtubule-dependent invasion to the HeLa epithelial cell line.

Authors:  P Goluszko; V Popov; R Selvarangan; S Nowicki; T Pham; B J Nowicki
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Acute renal failure in pregnancy.

Authors:  J E Ventura; M Villa; R Mizraji; R Ferreiros
Journal:  Ren Fail       Date:  1997-03       Impact factor: 2.606

4.  Gestational age-dependent distribution of Escherichia coli fimbriae in pregnant patients with pyelonephritis.

Authors:  B Nowicki; M Martens; A Hart; S Nowicki
Journal:  Ann N Y Acad Sci       Date:  1994-08-15       Impact factor: 5.691

5.  Role of decay-accelerating factor domains and anchorage in internalization of Dr-fimbriated Escherichia coli.

Authors:  R Selvarangan; P Goluszko; V Popov; J Singhal; T Pham; D M Lublin; S Nowicki; B Nowicki
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

6.  Lethal outcome of uterine infection in pregnant but not in nonpregnant rats and increased death rate with inhibition of nitric oxide.

Authors:  B Nowicki; L Fang; J Singhal; S Nowicki; C Yallampalli
Journal:  Am J Reprod Immunol       Date:  1997-10       Impact factor: 3.886

7.  Development of experimental model of chronic pyelonephritis with Escherichia coli O75:K5:H-bearing Dr fimbriae: mutation in the dra region prevented tubulointerstitial nephritis.

Authors:  P Goluszko; S L Moseley; L D Truong; A Kaul; J R Williford; R Selvarangan; S Nowicki; B Nowicki
Journal:  J Clin Invest       Date:  1997-04-01       Impact factor: 14.808

8.  Virulence factors and O groups of Escherichia coli isolates from patients with acute pyelonephritis, cystitis and asymptomatic bacteriuria.

Authors:  M Blanco; J E Blanco; M P Alonso; J Blanco
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

Review 9.  Urinary tract infections complicating pregnancy.

Authors:  F G Cunningham; M J Lucas
Journal:  Baillieres Clin Obstet Gynaecol       Date:  1994-06

10.  Gestational pyelonephritis--associated Escherichia coli isolates represent a nonrandom, closely related population.

Authors:  A Hart; T Pham; S Nowicki; E B Whorton; M G Martens; G D Anderson; B J Nowicki
Journal:  Am J Obstet Gynecol       Date:  1996-03       Impact factor: 8.661
View more
  11 in total

1.  Role of Src kinases in mobilization of glycosylphosphatidylinositol-anchored decay-accelerating factor by Dr fimbria-positive adhering bacteria.

Authors:  Christophe J Queval; Valérie Nicolas; Isabelle Beau
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

Review 2.  Covert operations of uropathogenic Escherichia coli within the urinary tract.

Authors:  Jean M Bower; Danelle S Eto; Matthew A Mulvey
Journal:  Traffic       Date:  2005-01       Impact factor: 6.215

Review 3.  Pili Assembled by the Chaperone/Usher Pathway in Escherichia coli and Salmonella.

Authors:  Glenn T Werneburg; David G Thanassi
Journal:  EcoSal Plus       Date:  2018-03

Review 4.  Pathogenesis of Afa/Dr diffusely adhering Escherichia coli.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 5.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Dra/AfaE adhesin of uropathogenic Dr/Afa+ Escherichia coli mediates mortality in pregnant rats.

Authors:  K Wroblewska-Seniuk; R Selvarangan; A Hart; R Pladzyk; P Goluszko; A Jafari; L du Merle; S Nowicki; C Yallampalli; C Le Bouguénec; B Nowicki
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 7.  Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis.

Authors:  S M Jacobsen; D J Stickler; H L T Mobley; M E Shirtliff
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

8.  Human decay-accelerating factor and CEACAM receptor-mediated internalization and intracellular lifestyle of Afa/Dr diffusely adhering Escherichia coli in epithelial cells.

Authors:  Julie Guignot; Sylvie Hudault; Imad Kansau; Ingrid Chau; Alain L Servin
Journal:  Infect Immun       Date:  2008-11-17       Impact factor: 3.441

9.  Adhesive threads of extraintestinal pathogenic Escherichia coli.

Authors:  Esther-Maria Antão; Lothar H Wieler; Christa Ewers
Journal:  Gut Pathog       Date:  2009-12-10       Impact factor: 4.181

Review 10.  Actin cytoskeleton manipulation by effector proteins secreted by diarrheagenic Escherichia coli pathotypes.

Authors:  Fernando Navarro-Garcia; Antonio Serapio-Palacios; Paul Ugalde-Silva; Gabriela Tapia-Pastrana; Lucia Chavez-Dueñas
Journal:  Biomed Res Int       Date:  2012-12-30       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.